HK1232289A1 - 分拣蛋白作为针对情感/心境障碍的生物标记的用途 - Google Patents
分拣蛋白作为针对情感/心境障碍的生物标记的用途 Download PDFInfo
- Publication number
- HK1232289A1 HK1232289A1 HK17105802.8A HK17105802A HK1232289A1 HK 1232289 A1 HK1232289 A1 HK 1232289A1 HK 17105802 A HK17105802 A HK 17105802A HK 1232289 A1 HK1232289 A1 HK 1232289A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sortilin
- biomarker
- affective
- mood disorders
- levels
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/304—Mood disorders, e.g. bipolar, depression
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201400075 | 2014-02-12 | ||
| DKPA201400075 | 2014-02-12 | ||
| PCT/EP2015/052506 WO2015121166A1 (en) | 2014-02-12 | 2015-02-06 | Use of sortilin as biomarker for affective/mood disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1232289A1 true HK1232289A1 (zh) | 2018-01-05 |
Family
ID=52462923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK17105802.8A HK1232289A1 (zh) | 2014-02-12 | 2015-02-06 | 分拣蛋白作为针对情感/心境障碍的生物标记的用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160349276A1 (https=) |
| EP (1) | EP3105594A1 (https=) |
| JP (1) | JP2017508144A (https=) |
| CN (1) | CN105980858A (https=) |
| HK (1) | HK1232289A1 (https=) |
| WO (1) | WO2015121166A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10849992B1 (en) | 2015-04-07 | 2020-12-01 | Alector Llc | Methods of screening for sortilin binding antagonists |
| CN107708733B (zh) | 2015-04-07 | 2022-11-15 | 艾利妥 | 抗分拣蛋白抗体和其使用方法 |
| FR3057267A1 (fr) * | 2016-10-11 | 2018-04-13 | Centre National De La Recherche Scientifique - Cnrs - | Procede de diagnostic/determination de l'efficacite de traitement de la depression |
| US11622948B2 (en) | 2017-11-09 | 2023-04-11 | The Trustees Of Columbia University In The City Of New York | Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders |
| US11491120B2 (en) | 2017-11-09 | 2022-11-08 | The Trustees Of Columbia University In The City Of New York | Pharmacological prophylactics against stress-induced affective disorders in females |
| TWI809147B (zh) | 2018-07-13 | 2023-07-21 | 美商阿列克特有限責任公司 | 抗分揀蛋白抗體及其使用方法 |
| CN111351945B (zh) * | 2020-03-18 | 2021-04-23 | 东南大学 | 维生素d结合蛋白作为标志物在精神疾病抑郁症诊断中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3165537A1 (en) * | 2008-12-19 | 2017-05-10 | H. Lundbeck A/S | Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders |
| GB0903417D0 (en) * | 2009-02-27 | 2009-04-08 | Cambridge Entpr Ltd | Biomarkers |
| GB0922240D0 (en) * | 2009-12-21 | 2010-02-03 | Cambridge Entpr Ltd | Biomarkers |
| GB201021502D0 (en) * | 2010-12-20 | 2011-02-02 | Cambridge Entpr Ltd | Biomarkers |
-
2015
- 2015-02-06 CN CN201580008112.4A patent/CN105980858A/zh active Pending
- 2015-02-06 HK HK17105802.8A patent/HK1232289A1/zh unknown
- 2015-02-06 WO PCT/EP2015/052506 patent/WO2015121166A1/en not_active Ceased
- 2015-02-06 JP JP2016551166A patent/JP2017508144A/ja active Pending
- 2015-02-06 US US15/117,967 patent/US20160349276A1/en not_active Abandoned
- 2015-02-06 EP EP15703275.6A patent/EP3105594A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017508144A (ja) | 2017-03-23 |
| EP3105594A1 (en) | 2016-12-21 |
| US20160349276A1 (en) | 2016-12-01 |
| CN105980858A (zh) | 2016-09-28 |
| WO2015121166A1 (en) | 2015-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1232289A1 (zh) | 分拣蛋白作为针对情感/心境障碍的生物标记的用途 | |
| PL3297644T3 (pl) | Metody terapii zaburzeń ze spektrum autyzmu i powiązanych objawów | |
| GB2551642B (en) | Methods and compositions relating to microbial treatment and diagnosis of disorders | |
| MX381640B (es) | Metodos y compuestos agonistas de gip. | |
| IL246917A0 (en) | Biomarker and early diagnosis methods for Alzheimer's disease | |
| IL282923A (en) | Methods and preparations for the diagnosis and treatment of disorders in patients with high levels of chemokine C.-X.-C. Ligand 9 and other biomarkers | |
| EA201890111A1 (ru) | Замещенные производные оксопиридина | |
| IL256166B (en) | Compounds for use in treating neuromuscular disorders | |
| HUE059559T2 (hu) | 5HT agonisták az epilepsziás rendellenességek kezelésére | |
| NZ720949A (en) | Methods and compositions for treating aging-associated conditions | |
| EA201591417A1 (ru) | Новый способ диагностики депрессии и мониторинга эффективности терапии | |
| LT3882250T (lt) | Tetrahidropiranilamino-pirolopirimidinonas, skirtas panaudoti btk nulemtų sutrikimų gydymui | |
| EP2560681A4 (en) | USE OF TAU FOR MONITORING IMMUNOTHERAPY | |
| EA201692529A1 (ru) | Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов | |
| FI20145492A7 (fi) | Menetelmä Parkinsonin taudin diagnostiikkaan, hoitoon ja estämiseen | |
| PT3200582T (pt) | Composições, kits e métodos para induzir citorresistência adquirida com utilização de indutores de proteínas de stress | |
| EA201790769A1 (ru) | Определение уровней гликозаминогликанов методом масс-спектрометрии | |
| EP3142664A4 (en) | Compositions and methods for treating and diagnosing ocular disorders | |
| MX2018000528A (es) | Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. | |
| EP3218481A4 (en) | Biomarkers useful in the treatment of subjects having diseases of the eye | |
| IN2014DN08398A (https=) | ||
| MA40406A (fr) | Procédés et compositions de diagnostic et de traitement des maladies inflammatoires chroniques de l'intestin | |
| MX377026B (es) | Biomarcadores para la progresión de enfermedades en melanoma. | |
| EP3307775A4 (en) | Methods for diagnosing and treating affective disorders | |
| SG11201706249RA (en) | Biomarkers for diagnosis and prognosis of corneal ectatic disorders |